- Home
- CPRX vs NHI Comparison
CPRX vs NHI Comparison
Compare CPRX & NHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- NHI
- Stock Information
- Founded
- CPRX 2002
- NHI 1991
- Country
- CPRX United States
- NHI United States
- Employees
- CPRX N/A
- NHI N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- NHI Real Estate Investment Trusts
- Sector
- CPRX Health Care
- NHI Real Estate
- Exchange
- CPRX Nasdaq
- NHI Nasdaq
- Market Cap
- CPRX 2.8B
- NHI 3.0B
- IPO Year
- CPRX 2006
- NHI 1991
- Fundamental
- Price
- CPRX $21.62
- NHI $68.99
- Analyst Decision
- CPRX Strong Buy
- NHI Buy
- Analyst Count
- CPRX 8
- NHI 7
- Target Price
- CPRX $32.25
- NHI $73.57
- AVG Volume (30 Days)
- CPRX 875.3K
- NHI 169.9K
- Earning Date
- CPRX 02-26-2025
- NHI 02-25-2025
- Dividend Yield
- CPRX N/A
- NHI 5.23%
- EPS Growth
- CPRX 114.68
- NHI 19.94
- EPS
- CPRX 1.18
- NHI 2.91
- Revenue
- CPRX $460,482,000.00
- NHI $329,848,000.00
- Revenue This Year
- CPRX $24.00
- NHI N/A
- Revenue Next Year
- CPRX $15.13
- NHI $14.12
- P/E Ratio
- CPRX $18.37
- NHI $23.97
- Revenue Growth
- CPRX 32.17
- NHI 6.05
- 52 Week Low
- CPRX $13.70
- NHI $56.70
- 52 Week High
- CPRX $24.64
- NHI $86.13
- Technical
- Relative Strength Index (RSI)
- CPRX 40.14
- NHI 51.70
- Support Level
- CPRX $22.18
- NHI $65.22
- Resistance Level
- CPRX $23.59
- NHI $70.38
- Average True Range (ATR)
- CPRX 0.70
- NHI 1.49
- MACD
- CPRX -0.17
- NHI 0.31
- Stochastic Oscillator
- CPRX 11.30
- NHI 68.83
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.
About NHI National Health Investors Inc.
National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments i.e. Real Estate Investments and Senior Housing Operating Portfolio. The Real Estate Investments segment consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived from rental income, mortgage and other notes receivable interest income, and resident fees and services.